B+
Bull case
20%
Probability
Target price
$16.08
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
CMPS
COMPASS PathwaysFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive late-stage readouts, constructive FDA interactions, and payer traction could re-rate COMPASS toward analyst upside within 12 months.
Posture
Defensive
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-11-02.
What can break
Binary clinical trial/readout failure
Momentum
29
Value
41
Sentiment
37
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $8.17 · Bull $16.08 · Bear $5.48Analysis 2026-02-26; returns require an exact persisted reference.
Earnings
2026-11-02
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-26 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-26 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-10-26
Investment thesis
As of 2026-10-26
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-26. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $23.35
Why
Momentum29 · Δ7d +5.9
Value41 · Δ7d -0.0
Sentiment37 · Δ7d -4.6
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-11-02.
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Binary clinical trial/readout failure
- • Dilution and financing needs
- • Trial failures, regulatory setbacks, or dilutive financings would compress multiples and push the share price materially lower.
Catalyst clock
2026-11-02
Analyst re-ratings / coverage updates
Lead driver: Value · See fundamentals
Momentum
29
8% active weight
Current posture
7d trendImproving
Δ7d
+5.9
Δ21d
-41.5
Value
41
47% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.4
Sentiment
37
45% active weight
Current posture
7d trendSoftening
Δ7d
-4.6
Δ21d
+0.0
Why this grade
Composite grade F. Momentum 28.8 / Value 40.6 / Sentiment 37.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-02-26. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$8.17
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$5.48
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$1.55B
Beta
1.93
Shares Out
138.48M
P/E (TTM) · Derived
-3.6
P/S (TTM)
-
P/FCF (TTM) · Derived
-7.79
Rev YoY
-
EPS YoY
+352.1%
Gross Margin
-
Op Margin
-
Net Debt
-$114.95M
Current Ratio
1.30
As of 2026-10-26 • Updated nightlySource: Internal modelMethods & Data